Home Page
Back to Home Page »
Contents
Slight increase in flu vaccine uptake in persons aged 65 years and older
EPIET and EUPHEM: Call for applications
Hepatitis E is now a notifiable disease
Polio Prevention - progress in Ireland but international challenges remain
HPSC publishes epidemiological report for 2014
Latest HPSC reports
Editorial Board
Dr D O'Flanagan, HPSC
(Managing editor)
Dr L Kyne, RCPI (Paed)
Prof C Bradley, ICGP
Dr N O'Sullivan, ISCM
Mr E O'Kelly, NVRL
Dr P McKeown, HPSC
Dr L Thornton, FPHMI
Prof C Bergin, IDSI
M Kelly, HSE
(Editor)

Health Protection Surveillance Centre

25-27 Middle Gardiner St
Dublin 1

Tel: +353 (0) 1 8765300
Fax: +353 (0) 1 8561299
info@hpsc.ie
www.hpsc.ie

Contents of Epi Insight should not be reproduced without permission.

© HPSC, 2016. All rights reserved

Subscribe

Enter your email address in the box below to receive an email each time we post a new issue of our newsletter.


Hepatitis E is now a notifiable disease

Hepatitis E has now been added to the list of notifiable diseases in Ireland. All medical practitioners and laboratories are required to notify hepatitis E to the Medical Officer of Health.

Hepatitis E virus is believed to be one of the most common causes of acute hepatitis worldwide with an increasing number of human cases being identified across Europe. Hepatitis E infection was traditionally associated with poor hygiene and transmission by the faecal-oral route in developing countries. However, it is now recognised as an emerging disease in many developed countries. Hepatitis E infections have been linked to the consumption of raw or undercooked pork or game meat. Transmission through occupational exposure to animals, particularly pigs, has also been reported. Hepatitis E has been found to be transmitted through infected blood products in several countries.

Hepatitis E is usually a self-limiting illness but it can result in liver failure in patients with pre-existing liver disease and in women infected during the third trimester of pregnancy. It may lead to chronic hepatitis in immunosuppressed patients.

Further information on hepatitis E

Lelia Thornton, HPSC

Newsletter Marketing Powered by Newsweaver